BlackRock’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-400,914
| Closed | -$541K | – | 5871 |
|
|
2021
Q4 | $541K | Sell |
400,914
-330,583
| -45% | -$446K | ﹤0.01% | 4774 |
|
|
2021
Q3 | $2.13M | Buy |
731,497
+21,877
| +3% | +$63.6K | ﹤0.01% | 4237 |
|
|
2021
Q2 | $2.48M | Sell |
709,620
-886,612
| -56% | -$3.09M | ﹤0.01% | 4101 |
|
|
2021
Q1 | $5.46M | Buy |
1,596,232
+8,116
| +0.5% | +$27.8K | ﹤0.01% | 3845 |
|
|
2020
Q4 | $30.5M | Buy |
1,588,116
+686,652
| +76% | +$13.2M | ﹤0.01% | 2723 |
|
|
2020
Q3 | $12.1M | Buy |
901,464
+2,627
| +0.3% | +$35.3K | ﹤0.01% | 3044 |
|
|
2020
Q2 | $38.1M | Buy |
898,837
+135,020
| +18% | +$5.72M | ﹤0.01% | 2378 |
|
|
2020
Q1 | $21.1M | Sell |
763,817
-108,486
| -12% | -$3M | ﹤0.01% | 2536 |
|
|
2019
Q4 | $28.3M | Buy |
872,303
+6,251
| +0.7% | +$203K | ﹤0.01% | 2656 |
|
|
2019
Q3 | $22.5M | Buy |
866,052
+287,229
| +50% | +$7.48M | ﹤0.01% | 2724 |
|
|
2019
Q2 | $21.2M | Buy |
578,823
+206,238
| +55% | +$7.57M | ﹤0.01% | 2786 |
|
|
2019
Q1 | $8.24M | Buy |
372,585
+28,516
| +8% | +$630K | ﹤0.01% | 3179 |
|
|
2018
Q4 | $4.84M | Buy |
344,069
+5,244
| +2% | +$73.8K | ﹤0.01% | 3379 |
|
|
2018
Q3 | $6.58M | Buy |
338,825
+4,566
| +1% | +$88.6K | ﹤0.01% | 3374 |
|
|
2018
Q2 | $7.38M | Buy |
334,259
+50,138
| +18% | +$1.11M | ﹤0.01% | 3342 |
|
|
2018
Q1 | $6.02M | Buy |
+284,121
| New | +$6.02M | ﹤0.01% | 3331 |
|